Thus we performed additional comprehensive meta-analysis including 14 studies (13 articles) with 2210 ovarian cancer patients, and the purpose was to assess the association of ALDH expression with overall survival (OS) and disease-free survival (DFS)/ progression-free survival (PFS) in ovarian cancer patients. This evidence concerns the gene LDHA and ovarian carcinoma.